Announcement of the Establishment of Carenet Clinical Research Operations, Inc. (Abbreviation: CCRO)
NQ Score
100/100
AI Summary (NQ-processed)
Carenet Co., Ltd.'s consolidated subsidiaries, Clayce Corporation and Satt Corporation, have completed an absorption-type merger with Clayce as the surviving company, effective April 1, 2026. Concurrently, the surviving company, Clayce, has changed its trade name to Carenet Clinical Research Operations, Inc. (CCRO). The new entity aims to provide advanced CRO services covering clinical development and clinical research by leveraging the expertise of both companies and Carenet's physician member and media platforms.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the new trade name of Clayce Corporation after the merger on April 1, 2026?
- A: The new trade name is Carenet Clinical Research Operations, Inc. (CCRO).
- Q: Which company is the surviving entity in the merger between Clayce and Satt Corporation effective April 1, 2026?
- A: Clayce Corporation is the surviving entity in the merger.
- Q: What date marks the official establishment of Carenet Clinical Research Operations, Inc. (CCRO)?
- A: The official establishment date of CCRO is April 1, 2026.
- Q: What abbreviation is used for Carenet Clinical Research Operations, Inc. after the April 1, 2026 rebranding?
- A: The abbreviation used is CCRO.
- Q: Which parent company oversees CCRO following the April 1, 2026 merger of Clayce and Satt?
- A: Carenet Co., Ltd. is the parent company overseeing CCRO.